HIGH-DOSE BUSULFAN AND HIGH-DOSE CYCLOPHOSPHAMIDE FOLLOWED BY DONOR BONE MARROW TRANSPLANT IN TREATING PATIENTS WITH LEUKEMIA, MYELODYSPLASTIC SYNDROME, MULTIPLE MYELOMA, OR RECURRENT HODGKIN OR NON-HODGKIN LYMPHOMA: